These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 3494215
21. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B. Kindt MV, Heikkila RE. Life Sci; 1986 Apr 21; 38(16):1459-62. PubMed ID: 3084895 [Abstract] [Full Text] [Related]
22. The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity. Arai Y, Toyoshima Y, Kinemuchi H, Tadano T, Kisara K. Neurosci Lett; 1986 Oct 08; 70(2):266-71. PubMed ID: 3490638 [Abstract] [Full Text] [Related]
24. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice. Fuller RW, Hemrick-Luecke SK, Kindt MV, Heikkila RE. Life Sci; 1988 Oct 08; 42(3):263-71. PubMed ID: 3121972 [Abstract] [Full Text] [Related]
26. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase. Naoi M, Nagatsu T. Life Sci; 1987 Mar 16; 40(11):1075-82. PubMed ID: 3821373 [Abstract] [Full Text] [Related]
27. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl. Fuller RW, Hemrick-Luecke SK. Life Sci; 1986 Nov 03; 39(18):1645-50. PubMed ID: 3095601 [Abstract] [Full Text] [Related]
28. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Fuller RW, Hemrick-Luecke SK. J Pharmacol Exp Ther; 1985 Mar 03; 232(3):696-701. PubMed ID: 3871853 [Abstract] [Full Text] [Related]
30. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion. Hirata Y, Nagatsu T. Neurosci Lett; 1985 Jun 24; 57(3):301-5. PubMed ID: 3929190 [Abstract] [Full Text] [Related]
34. Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors. Herraiz T, Guillén H. Food Chem Toxicol; 2011 Aug 01; 49(8):1773-81. PubMed ID: 21554916 [Abstract] [Full Text] [Related]
35. Processing of MPTP by monoamine oxidases: implications for molecular toxicology. Trevor AJ, Singer TP, Ramsay RR, Castagnoli N. J Neural Transm Suppl; 1987 Aug 01; 23():73-89. PubMed ID: 3295117 [Abstract] [Full Text] [Related]
37. Photoinactivation of B-type monoamine oxidase by a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolite. Buckman TD, Eiduson S. J Biol Chem; 1985 Oct 05; 260(22):11899-902. PubMed ID: 3876335 [Abstract] [Full Text] [Related]
38. Metabolism of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a rat pheochromocytoma cell line, PC12h. Naoi M, Takahashi T, Nagatsu T. Life Sci; 1987 Dec 14; 41(24):2655-61. PubMed ID: 3121966 [Abstract] [Full Text] [Related]
39. MPTP, MPP+ and mitochondrial function. Nicklas WJ, Youngster SK, Kindt MV, Heikkila RE. Life Sci; 1987 Feb 23; 40(8):721-9. PubMed ID: 3100899 [Abstract] [Full Text] [Related]
40. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae. Trevor AJ, Castagnoli N, Caldera P, Ramsay RR, Singer TP. Life Sci; 1987 Feb 23; 40(8):713-9. PubMed ID: 3492651 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]